Next-Gen Antibody Therapeutics Market to Reach $22.88 Billion by 2033
The next-generation antibody therapeutics market is projected to grow from $9.09 billion in 2024 to $22.88 billion by 2033, driven by advancements in oncology and AI-driven drug design, according to a press release by DataM Intelligence.